Transurethral Ultrasound Ablation for Treatment of Localized Prostate Cancer and Benign Prostatic Hyperplasia (BPH)
Journal of Endourology · 2025
DOI: 10.1089/end.2024.0301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Endourology, 2025. Verfasst von Lucas Engelage und 1 weiteren Autor:innen. Beteiligte Einrichtung: ALTA Klinik, Bielefeld, Germany. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatic Hyperplasia, Transurethral Resection of Prostate. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Indications: Transurethral ultrasound ablation (TULSA) is used for treating localized prostate cancer and benign prostatic hyperplasia (BPH). It’s particularly suitable for patients with low to intermediate risk, uni- and multifocal organ-confined prostate carcinomas, symptomatic obstructive BPH coinciding with prostate cancer, and postradiation therapy recurrences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- ALTA Klinik, Bielefeld, Germany.
ORCID-Profile: Rolf Muschter
Zitieren
APA
Engelage, L., & Muschter, R. (2025). Transurethral Ultrasound Ablation for Treatment of Localized Prostate Cancer and Benign Prostatic Hyperplasia (BPH). Journal of Endourology. https://doi.org/10.1089/end.2024.0301
Vancouver
Engelage L, Muschter R. Transurethral Ultrasound Ablation for Treatment of Localized Prostate Cancer and Benign Prostatic Hyperplasia (BPH). Journal of Endourology. 2025. doi:10.1089/end.2024.0301
BibTeX
@article{Engelage2025,
author = {Engelage, Lucas and Muschter, Rolf},
title = {Transurethral Ultrasound Ablation for Treatment of Localized Prostate Cancer and Benign Prostatic Hyperplasia (BPH)},
journal = {Journal of Endourology},
year = {2025},
doi = {10.1089/end.2024.0301}
}
EUVIMED